Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

Related Citations for PubMed (Select 9765614)

1.

Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.

Arisawa K, Soda M, Akahoshi M, Matsuo T, Nakashima E, Tomonaga M, Saito H.

Jpn J Cancer Res. 1998 Aug;89(8):797-805.

PMID:
9765614
2.

Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan.

Arisawa K, Soda M, Akahoshi M, Fujiwara S, Uemura H, Hiyoshi M, Takeda H, Kashino W, Suyama A.

Cancer Sci. 2006 Jun;97(6):535-9.

PMID:
16734733
3.

Mortality among inhabitants of an HTLV-I endemic area in Japan.

Iwata K, Ito S, Saito H, Ito M, Nagatomo M, Yamasaki T, Yoshida S, Suto H, Tajima K.

Jpn J Cancer Res. 1994 Mar;85(3):231-7.

PMID:
8188520
4.

Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.

Arisawa K, Sobue T, Yoshimi I, Soda M, Shirahama S, Doi H, Katamine S, Saito H, Urata M.

Cancer Causes Control. 2003 Nov;14(9):889-96.

PMID:
14682446
5.

A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.

Boschi-Pinto C, Stuver S, Okayama A, Trichopoulos D, Orav EJ, Tsubouchi H, Mueller N.

J Infect Dis. 2000 Jan;181(1):35-41.

6.

Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.

Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE.

Blood. 1998 Nov 15;92(10):3557-61.

7.

A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.

Arisaw K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M, Doi H, Saito H, Shirahama S.

Cancer Causes Control. 2002 Sep;13(7):657-63.

PMID:
12296513
8.

Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I.

Hisada M, Okayama A, Spiegelman D, Mueller NE, Stuver SO.

Int J Cancer. 2001 Feb 15;91(4):497-9.

PMID:
11251972
9.

Human T lymphotropic virus type 1 infection and gastric cancer development in Japan.

Matsumoto S, Yamasaki K, Tsuji K, Shirahama S.

J Infect Dis. 2008 Jul 1;198(1):10-5. doi: 10.1086/588733.

10.

HCV infection and liver cancer mortality in a Japanese population with HTLV-I.

Stuver SO, Okayama A, Tachibana N, Tsubouchi H, Mueller NE, Tabor E.

Int J Cancer. 1996 Jul 3;67(1):35-7.

PMID:
8690522
11.

Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia.

Kamihira S, Momita S, Ikeda S, Yamada Y, Sohda H, Atogami S, Tomonaga M, Kinoshita K, Toriya K, Furukawa R.

Jpn J Med. 1991 Nov-Dec;30(6):492-7.

12.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
13.

Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study.

Lechat MF, Shrager DI, Declercq E, Bertrand F, Blattner WA, Blumberg BS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):387-90.

PMID:
9342260
14.

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.

PMID:
16908797
15.

Geographic distribution of the incidence of adult T-cell leukemia/lymphoma and other malignancies in nagasaki prefecture, Japan.

Arisawa K, Soda M, Shirahama S, Saito H, Takamura N, Yamaguchi M, Odagiri K, Nakagoe T, Suyama A, Doi H.

Jpn J Clin Oncol. 2002 Aug;32(8):301-6.

16.

Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors.

Matsuo T, Nakashima E, Carter RL, Neriishi K, Mabuchi K, Akiyama M, Shimaoka K, Kinoshita K, Tomonaga M, Ichimaru M.

J Radiat Res. 1995 Mar;36(1):8-16.

17.

Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus.

Okayama A, Maruyama T, Tachibana N, Hayashi K, Kitamura T, Mueller N, Tsubouchi H.

Jpn J Cancer Res. 1995 Jan;86(1):1-4.

PMID:
7737899
18.

Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study.

Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA.

Int J Epidemiol. 2005 Feb;34(1):132-7. Epub 2005 Jan 19.

19.

Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA.

Goedert JJ, Fung MW, Felton S, Battjes RJ, Engels EA.

AIDS. 2001 Jul 6;15(10):1295-302.

PMID:
11426075
20.

Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.

Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S.

Am J Epidemiol. 1993 Jan 1;137(1):43-8.

PMID:
8434571
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk